DNA, D(P-THIO)(C-A-C-C-C-A-C-C-C-A-A-G-A-A-C-A-G-G)
Gall Bladder Cancer
Andes Biotechnologiesnucleic_acidPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
16 Active assets in the Gall Bladder Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin Tianjin Medical University Cancer Institute and Hospital | Phase 3 | BB |
Irinotecan Merck Sharp & Dohme LLC | Phase 2 | BB |
Cyclophosphamide Merck Sharp & Dohme LLC | Phase 2 | BB |
Docetaxel Merck Sharp & Dohme LLC | Phase 2 | BB |
Epirubicin Merck Sharp & Dohme LLC | Phase 2 | BB |
View all 21 →
Same molecule, other indications
DNA, D(P-THIO)(C-A-C-C-C-A-C-C-C-A-A-G-A-A-C-A-G-G) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →